top of page

GSP Crop Science IPO Opens for Subscription: Price Band, GMP, and Key Details Investors Should Know

  • iamramdharsan
  • 3 hours ago
  • 3 min read

GSP Crop Science IPO Opens: What Investors Need to Know

The initial public offering (IPO) of GSP Crop Science has officially opened for public subscription on March 16, 2026, attracting attention from investors in India’s growing agrochemical sector. The company plans to raise approximately ₹400 crore through this public issue, which will remain open until March 18, 2026.

GSP Crop Science IPO opens for subscription with price band ₹304 to ₹320 per share
The IPO of GSP Crop Science opened for investors with a price band of ₹304–₹320 per share.

The IPO consists of a fresh issue worth ₹240 crore and an offer for sale (OFS) worth ₹160 crore by promoters, allowing existing shareholders to partially exit while the company raises capital for business needs.


GSP Crop Science IPO Price Band and Lot Size

The company has fixed the price band between ₹304 and ₹320 per share for the public offering. Investors interested in participating must apply for a minimum lot size of 46 shares, which requires an investment of around ₹14,720 at the upper price band.


Key IPO Details

  • IPO Opening Date: March 16, 2026

  • IPO Closing Date: March 18, 2026

  • Price Band: ₹304 – ₹320 per share

  • Lot Size: 46 shares

  • Issue Size: ₹400 crore

  • Listing: BSE and NSE

  • Expected Listing Date: March 24, 2026


Day 1 Subscription Status

On the first day of bidding, the IPO saw very slow demand in early hours, with the overall issue subscribed around 0.01 times, while the retail category saw about 0.02 times subscription.


This indicates that investors may wait for later sessions or institutional participation before placing large bids.


Grey Market Premium (GMP) Signals Neutral Sentiment

According to market observers, the grey market premium (GMP) for the IPO is currently around ₹0, meaning the shares are trading at their issue price in the unofficial market.

A GMP of zero typically suggests:

  • Neutral investor sentiment

  • Limited listing gains expectations

  • Investors waiting for subscription momentum

However, GMP can change rapidly depending on market demand and subscription levels during the IPO period.


About the Company

GSP Crop Science is a research-driven agrochemical company that manufactures products such as:

  • Herbicides

  • Insecticides

  • Fungicides

  • Plant growth regulators

These products are widely used in the agricultural sector to improve crop yield and protect plants from pests and diseases.


The company has been operating in the agrochemical industry for several decades and supplies products to both domestic and international markets.


How the IPO Funds Will Be Used

A significant portion of the funds raised from the IPO will be used to repay outstanding borrowings and strengthen the company’s financial position. The remaining amount will be allocated for general corporate purposes and business expansion.


Reducing debt is expected to improve the company’s balance sheet and operational flexibility.


Should Investors Consider This IPO?

Market experts say the IPO could attract long-term investors interested in the agriculture and agrochemical sector, which continues to grow due to rising global food demand.


However, the flat grey market premium and slow early subscription suggest that investors may remain cautious until stronger demand emerges during the later stages of the issue.


As always, investors should evaluate:

  • Company financials

  • Industry outlook

  • Valuation compared with peers

before making an investment decision.


Conclusion

The GSP Crop Science IPO marks another entry into India’s primary market from the agrochemical sector. With a ₹400 crore issue size and price band of ₹304–₹320, the IPO offers investors exposure to an agriculture-focused company, though early indicators show neutral market sentiment.


As subscription progresses over the next few days, investor participation and grey market trends will determine whether the IPO generates strong listing gains or remains a long-term investment play.

Comments


info@revealtheews.com

©2022 by Reveal the News. Proudly created with Wix.com

bottom of page